TABLE 2

TTE measurement of LV dimensions and regional function 4 weeks after I/R

All data are presented as mean ± S.E.M. *P < 0.05; **P < 0.01; **P < 0.001 versus CON.

Treatment	No.	IVSd	IVSs	WT_IVS	LVPWd	LVPWs	WT_PW	HR
		mm	mm	%	mm	mm	%	BPM
CON	11	1.07 ± 0.05	1.31 ± 0.004	24 ± 6	1.05 ± 0.03	1.23 ± 0.004	18 ± 4	395 ± 16
TAD	12	0.93 ± 0.02 **	1.30 ± 0.01	40 ± 3	0.99 ± 0.01	1.23 ± 0.005	25 ± 1	452 ± 17
iNO	10	0.90 ± 0.03 **	1.32 ± 0.002	48 ± 5 **	0.94 ± 0.03 *	1.27 ± 0.015 **	35 ± 5 **	442 ± 14
iNO+TAD	13	0.87 ± 0.02 **	1.32 ± 0.007	52 ± 3 ***	0.93 ± 0.02 **	1.23 ± 0.003	32 ± 2 *	450 ± 19

BPM beats per minute; HR, heart rate in; IVSd and IVSs, diastolic and systolic interventricular septal thickness; LVPWd and LVPWs, diastolic and systolic left ventricular posterior wall thickness; WT_IVS and WT_PW, percentage of interventricular septal and posterior wall thickening.